GeoVax Advances Mpox Vaccine Development Amid Global Outbreak Concerns
The global health community faces a growing challenge as Mpox outbreaks, caused by both Clade I and Clade II strains, expand across continents. GeoVax Labs, Inc. has highlighted the critical need for diversified vaccine supplies, especially with the recent Scientific Advice from the European Medicines Agency (EMA) supporting an expedited development pathway for its GEO-MVA […]